| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/17/1991 | EP0422186A1 Methods for controlling human endothelial cell proliferation and effector functions using oncostatin m |
| 04/17/1991 | EP0421997A1 Use of a glycine b partial agonist for memory and learning enhancement or treatment of a cognitive disorder |
| 04/16/1991 | US5008292 Pesticidal method |
| 04/16/1991 | US5008280 2-iminobenzothiazoline derivatives, their preparation and pharmaceutical compositions containing them |
| 04/16/1991 | US5008272 Antagonists; useful in treatment of psychotic disorders, central nervous system disorder; antidepressant |
| 04/16/1991 | CA1283104C Trans-benzopyran-[4,3b]-1,4-oxazine derivatives |
| 04/15/1991 | WO1991005783A1 Heterocyclic compounds |
| 04/14/1991 | WO1991005754A2 Derivatives of long-chain fatty alcohols and their applications, in particular as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing same |
| 04/14/1991 | CA2044162A1 Long-chained fatty alcohol derivatives, their applications, specifically as cytotrphic and cytoprotecting molecules, and pharmaceutical compounds containing same |
| 04/14/1991 | CA2027325A1 6-substituted-1,2,3,4-tetrahydroisoquinolines |
| 04/13/1991 | WO1991005801A1 Dopamine releasing protein |
| 04/13/1991 | WO1991005570A1 Radiation synovectomy compositions |
| 04/13/1991 | CA2065442A1 Dopamine releasing protein |
| 04/13/1991 | CA2027485A1 Process for the preparation of isoxazolyl, isothiazolyl, imidazobenzodiazepines, new derivatives obtained thereby, their use as drugs, and compositions containing these products |
| 04/11/1991 | WO1991005787A1 Iminomethanodibenzo(a,d)cycloheptene derivatives as neuroprotectant agents |
| 04/11/1991 | CA2067351A1 Neuroprotectant agents |
| 04/11/1991 | CA2027262A1 Phenethanolamine derivatives |
| 04/10/1991 | WO1991004973A1 Indole derivatives, their preparation and use |
| 04/10/1991 | EP0421581A1 Chewable spray dried spheroidal microcapsules and wax coated microcapsules and methods for preparing same |
| 04/10/1991 | EP0421365A2 Tetrazoleacetic acid derivatives having aldose reductase inhibitory activity |
| 04/10/1991 | EP0421199A2 (+)-(2-Hydroxy)-2-adamantyl)-1-imidazolyl-3-tolyl-methane and its salts, process for its preparation, medicine containing this compound and its use |
| 04/10/1991 | EP0421074A1 Pharmacologically active peptides and pharmaceutical preparations containing them |
| 04/10/1991 | EP0420871A1 Method and compositions for treatment of parkinsonism syndrome in mammals |
| 04/10/1991 | CA2067181A1 Indole derivatives, their preparation and use |
| 04/09/1991 | US5006570 Dihydrobenzofuran- and chroman-carboxamide derivatives, processes for the preparation thereof and use thereof as neuroleptics |
| 04/09/1991 | US5006560 Use of GABA-B selective agonists as anti-tussive agents |
| 04/09/1991 | US5006544 5-hydroxytryptamine antagonist for psychological and gastrointestinal disorders; anxiolytic agents |
| 04/09/1991 | US5006536 Thienobenzoxepins and analgesic compositions thereof |
| 04/09/1991 | US5006533 Neuroleptic agents, side effect reduction |
| 04/09/1991 | US5006531 5,6-dihydro(1H-indolo(3,2-C)quinoline-6,4'-piperidines) and related compounds which are useful for treating pain, psychosis or convulsions |
| 04/09/1991 | US5006522 Condensed diazepinones, processes for preparing them and pharmaceutical compositions containing these compounds |
| 04/09/1991 | US5006518 Hormone inhibitors for inducing abortions; nontoxic |
| 04/09/1991 | CA1282784C Decahydroquinolein derivatives, process for their preparation, intermediates, use as medicaments and compositions comprising the same |
| 04/09/1991 | CA1282781C 5-[(3-chloro-6-methyl-5,5-dioxo-6,11-dihydrodibenzo [c,f] [1,2] thiazepin-11-yl) amino] pentanoic acid, a new tricyclic derivative; process for preparing the same |
| 04/08/1991 | CA2027093A1 Compounds |
| 04/04/1991 | WO1991004032A1 Methods of treating neurodegenerative conditions |
| 04/04/1991 | WO1990014067A3 Methods for treating anxiety with sigma receptor ligands |
| 04/04/1991 | CA2026707A1 Chewable spray dried spheroidal microcapsules and wax coated microcapsules and methods for preparing same |
| 04/03/1991 | EP0420806A1 Phosphonic acids, process for preparation and use as an active pharmaceutical composition |
| 04/03/1991 | EP0420716A2 Benzodiazepines, process and intermediates for their preparation and their therapeutic use |
| 04/03/1991 | EP0420470A2 Naphthopyran compounds |
| 04/03/1991 | EP0420264A2 Transdermal delivery of (+)(2S,3S)-3-acetoxy-8-chloro-5-(2-dimethyl-aminoethyl)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4-(5H)-one |
| 04/03/1991 | EP0420140A2 N-Aminocarbamates related to physostigmine, a process for their preparation and their use as medicaments |
| 04/03/1991 | EP0420120A2 Optically active benzyl alcohol compound and pharmaceutical composition |
| 04/03/1991 | EP0420086A2 Pyrimidoindole derivatives and processes for preparation thereof |
| 04/03/1991 | EP0420064A2 Substituted 2-amidotetralins as melatonin agonists and antagonists |
| 04/03/1991 | EP0419878A1 Aprotinin variants and a recombinant method for the microbial preparation of these variants in homogeneously processed form |
| 04/03/1991 | EP0419844A1 N-hydroxy-dibenz[b,e]oxepin-alkylamines and -alkanoic acid amides, related heterocyclic analogues, a process for their preparation and their use in the manufacture of medicaments |
| 04/03/1991 | CN1050387A Antagonist of n-methyl-d-aspartic acid |
| 04/03/1991 | CN1050382A Pyrazole derivatives, processes for preparation thereof and pharmaceutical composition comprising the same |
| 04/02/1991 | US5004826 Substituted propane-phosphonous acid compounds |
| 04/02/1991 | US5004755 Pharmaceutical use of laevorotatory basic derivative of 9,10-ethanoanthracene |
| 04/02/1991 | US5004747 Isoquinolinones |
| 04/02/1991 | CA1282413C Alkylcarboxamides of pyridylalkylamines, their preparation and their use in human and veterinary medicine |
| 04/02/1991 | CA1282410C Process for the preparation of optically active ó-arylalkanoic acids and novel intermediates thereof |
| 04/02/1991 | CA1282334C 2-¬(3,5-dihalo-4-aminobenzyl)| imidazolines |
| 04/02/1991 | CA1282333C Nutritional agent for the cerebrospinal nervous system |
| 03/30/1991 | CA2026293A1 Transdermal delivery of (+)(2s,3s)-3-acetoxy-8-chloro-5-(2-dimethylaminoethyl)-2,3- dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4-(5h)-one |
| 03/29/1991 | CA2026381A1 N-aminocarbamates related to physostigmine, a process for their preparation and their use as medicaments |
| 03/29/1991 | CA2026123A1 Benzodiazepines, their process of production, intermediate products and applications in therapeutic practice |
| 03/27/1991 | WO1991004733A1 Ibuprofen triturates and topical compositions containing same |
| 03/27/1991 | EP0419397A1 Substituted urea compounds and their preparation and use |
| 03/27/1991 | EP0419360A1 Phenothiazine derivatives, their preparation and pharmaceutical compositions containing them |
| 03/27/1991 | EP0419247A2 Selective GABA antagonists, especially isoquinoline derivatives, and their use for treating CNS disorders |
| 03/27/1991 | EP0419157A2 Pharmacologically active compound., preparation and use |
| 03/27/1991 | EP0419135A2 Use of 1,3-di-n-butyl-7-(2-oxopropyl)xanthine for treating disorders resulting from cerebral ischemia |
| 03/27/1991 | EP0419049A1 (Quinolin-2-ylmethoxy) indoles as inhibitors of the biosynthesis of leukotrienes |
| 03/27/1991 | EP0418990A2 13-Bromo and 13,14-dibromo ergoline, their preparation and their use |
| 03/27/1991 | EP0418863A2 NMDA antagonists |
| 03/27/1991 | EP0418845A1 Pyrazole derivatives, processes for preparation thereof and pharmaceutical composition comprising the same |
| 03/27/1991 | EP0418716A1 Thienylcarboxylic acid ester of aminoalcohols, their quaternary products, their preparation and use of the compounds |
| 03/27/1991 | EP0418564A1 Effervescent cold or sinus allergy medicine composition having reduced sodium content |
| 03/27/1991 | EP0418230A1 Method for potentiating and inhibiting insulin-like growth factor activity. |
| 03/27/1991 | CN1050198A Peptidase and isomerase inhibitors |
| 03/27/1991 | CN1050185A Process for preparing clausenamide and neoclausenamide, and of their derivatives |
| 03/27/1991 | CA2067131A1 Ibuprofen triturates and topical compositions containing same |
| 03/27/1991 | CA2026038A1 4-substituted 2-aminoalk-3-enoic acids |
| 03/26/1991 | US5002966 Adrenergic Stimulants |
| 03/26/1991 | US5002963 Central Nervous System Disorders |
| 03/26/1991 | US5002948 Central Nervous System Disorders |
| 03/26/1991 | US5002773 Transdermal delivery of (+) (2S,3S)-3-acetoxy-8-chloro-5-(2-dimethylaminoethyl)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4-(5H)-one |
| 03/26/1991 | CA2025958A1 Substituted 2-amidotetralins as melatonin agonists and antagonists |
| 03/26/1991 | CA2025820A1 Pyrimidoindole derivatives and processes for preparation thereof |
| 03/26/1991 | CA1282072C 1-styrene sulfonyl 2-oxo 5-hydroxy pyrrolidine derivatives, process and intermediates for their preparation, use as medicaments and compositions therefrom |
| 03/24/1991 | CA2025941A1 Cns-active hexapeptides with an antiamnesic effect |
| 03/22/1991 | CA2025930A1 Phenothiazine derivatives, process for their preparation and pharmaceutical compositions containing the same |
| 03/21/1991 | WO1991003467A1 Benzazabicyclic carbamates as novel cholinesterase inhibitors |
| 03/21/1991 | WO1991003233A1 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs |
| 03/21/1991 | WO1991000856A3 (1,2n) and (3,2n)-carbocyclic-2-amino tetralin derivatives |
| 03/21/1991 | CA2025744A1 13-bromo-and 13,14-dibromoergolines, their production and use in medicinal agents |
| 03/21/1991 | CA2025719A1 Method of treatment & heterocyclic compounds used therein |
| 03/20/1991 | EP0418065A2 Dihydrocaffeic acid derivatives, use thereof for medical treatments and pharmaceutical preparations containing same |
| 03/20/1991 | EP0417819A1 Psycho-pharmacological peptides |
| 03/20/1991 | EP0417790A2 S-triazolo[3,4-i]purine derivatives |
| 03/20/1991 | EP0417721A2 Novel peptidase and isomerase inhibitors |
| 03/20/1991 | EP0417653A1 3-(1-Substituted-4-piperazinyl)-1H-indazoles, a process for their preparation and their use as medicaments |
| 03/20/1991 | EP0417637A2 Use of dopamine autoreceptor agonists in the treatment of drug dependency |
| 03/20/1991 | EP0417584A2 N-substituted-4-pyrimidinamines and -pyrimidindiamines, a process for their preparation and their use as medicaments |
| 03/20/1991 | EP0417245A1 Topical analgesic composition |
| 03/20/1991 | EP0417113A1 Preparation of carbamic acid ester for the treatment of addiction to alcohol |